These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 25681534

  • 1. Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study.
    Molinet-Dronda F, Gago B, Quiroga-Varela A, Juri C, Collantes M, Delgado M, Prieto E, Ecay M, Iglesias E, Marín C, Peñuelas I, Obeso JA.
    Neurobiol Dis; 2015 May; 77():165-72. PubMed ID: 25681534
    [Abstract] [Full Text] [Related]

  • 2. PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data.
    Tang J, Xu Y, Liu C, Fang Y, Cao S, Zhao C, Huang H, Zou M, Chen Z.
    Nucl Med Biol; 2020 May; 90-91():1-9. PubMed ID: 32861175
    [Abstract] [Full Text] [Related]

  • 3. In vivo measurement of density and affinity of the monoamine vesicular transporter in a unilateral 6-hydroxydopamine rat model of PD.
    Sossi V, Holden JE, Topping GJ, Camborde ML, Kornelsen RA, McCormick SE, Greene J, Studenov AR, Ruth TJ, Doudet DJ.
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1407-15. PubMed ID: 17245418
    [Abstract] [Full Text] [Related]

  • 4. In vivo dopamine transporter imaging in a unilateral 6-hydroxydopamine rat model of Parkinson disease using 11C-methylphenidate PET.
    Sossi V, Dinelle K, Jivan S, Fischer K, Holden JE, Doudet D.
    J Nucl Med; 2012 May; 53(5):813-22. PubMed ID: 22492730
    [Abstract] [Full Text] [Related]

  • 5. Comparative assessment of 6-[18 F]fluoro-L-m-tyrosine and 6-[18 F]fluoro-L-dopa to evaluate dopaminergic presynaptic integrity in a Parkinson's disease rat model.
    Becker G, Bahri MA, Michel A, Hustadt F, Garraux G, Luxen A, Lemaire C, Plenevaux A.
    J Neurochem; 2017 May; 141(4):626-635. PubMed ID: 28294334
    [Abstract] [Full Text] [Related]

  • 6. Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease.
    Casteels C, Lauwers E, Bormans G, Baekelandt V, Van Laere K.
    Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):124-34. PubMed ID: 17906859
    [Abstract] [Full Text] [Related]

  • 7. In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET.
    Fischer K, Sossi V, von Ameln-Mayerhofer A, Reischl G, Pichler BJ.
    Neuroimage; 2012 Feb 01; 59(3):2413-22. PubMed ID: 21945469
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Bilateral increase in striatal dopamine D2 receptor density in the 6-hydroxydopamine-lesioned rat: a serial in vivo investigation with small animal PET.
    Nikolaus S, Larisch R, Beu M, Forutan F, Vosberg H, Müller-Gärtner HW.
    Eur J Nucl Med Mol Imaging; 2003 Mar 01; 30(3):390-5. PubMed ID: 12634967
    [Abstract] [Full Text] [Related]

  • 14. Characterization of gray matter atrophy following 6-hydroxydopamine lesion of the nigrostriatal system.
    Westphal R, Sumiyoshi A, Simmons C, Mesquita M, Wood TC, Williams SC, Vernon AC, Cash D.
    Neuroscience; 2016 Oct 15; 334():166-179. PubMed ID: 27506141
    [Abstract] [Full Text] [Related]

  • 15. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
    Weng CC, Chen ZA, Chao KT, Ee TW, Lin KJ, Chan MH, Hsiao IT, Yen TC, Kung MP, Hsu CH, Wey SP.
    PLoS One; 2017 Oct 15; 12(3):e0173503. PubMed ID: 28257461
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats.
    Inaji M, Okauchi T, Ando K, Maeda J, Nagai Y, Yoshizaki T, Okano H, Nariai T, Ohno K, Obayashi S, Higuchi M, Suhara T.
    Brain Res; 2005 Dec 07; 1064(1-2):136-45. PubMed ID: 16298352
    [Abstract] [Full Text] [Related]

  • 18. The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
    Metz GA, Tse A, Ballermann M, Smith LK, Fouad K.
    Eur J Neurosci; 2005 Aug 07; 22(3):735-44. PubMed ID: 16101755
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.